ClinVar Miner

Submissions for variant NM_000260.4(MYO7A):c.4006C>T (p.Gln1336Ter)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Fulgent Genetics,Fulgent Genetics RCV000763281 SCV000893925 pathogenic Deafness, autosomal dominant 11; Deafness, autosomal recessive 2; Usher syndrome, type 1 2018-10-31 criteria provided, single submitter clinical testing
GeneID Lab - Advanced Molecular Diagnostics RCV000680440 SCV000807812 likely pathogenic Usher syndrome, type 1B 2018-03-10 criteria provided, single submitter clinical testing This variant produces a premature stop signal at position 1336 of the MYO7A protein, designated as p.Gln1336Ter or Q1336*. The substitution is predicted to result in a non-functional protein, either through protein truncation or nonsense-mediated mRNA decay. This mutation is considered a non-tolerated amino acid change based on in silico prediction algorithms (disease causing), and it has not been reported in the ClinVar Database (NCBI National Library of Medicine, NIH), but it has been described in 3 alleles out of 120168 belonging to heterozygous carries of Latino origin by the Exome Aggregation Consortium (ExAC). Based on these findings and the limited literature regarding this substitution we consider it as a likely pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.